geniposide has been researched along with Fatty Liver, Nonalcoholic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Y; Hu, YY; Leng, J; Peng, JH; Tian, HJ | 1 |
| Fang, Y; Hu, Y; Liu, W; Peng, J; Tang, H; Tian, H; Wang, J; Yin, Y; Zhao, J | 1 |
| Cheng, J; Feng, H; Jin, M; Li, Z; Liu, G; Qin, H; Shen, B; Wang, Q; Zhao, L | 1 |
| Baker, RD; Baker, SS; Chen, C; Feng, Q; Guan, L; Hu, Y; Kozielski, R; Li, H; Liu, P; Liu, Q; Liu, W; Peng, J; Tang, S; Tsompana, M; Zhu, L; Zhu, R | 1 |
| Chen, SD; Li, GH; Liang, HQ; Lin, MT; Wang, HG; Wang, YJ; Wang, YY; Zhang, LM; Zhao, X; Zhou, HH | 1 |
| Chae, HJ; Kim, HK; Kim, HR; Kim, SH; Lee, GH; Lee, HY; Lee, MR | 1 |
| Huang, C; Li, J; Ma, T; Meng, X; Tang, W; Zha, D; Zong, G | 1 |
7 other study(ies) available for geniposide and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Amelioration of Non-Alcoholic Steatohepatitis by
Topics: Animals; Atractylodes; Chlorogenic Acid; Endotoxins; Iridoids; Lipopolysaccharides; Liver; Mice; Non-alcoholic Fatty Liver Disease | 2022 |
Inhibition on XBP1s-driven lipogenesis by Qushi Huayu Decoction contributes to amelioration of hepatic steatosis induced by fructose.
Topics: Animals; Chlorogenic Acid; Endoribonucleases; Fructose; Ligases; Lipogenesis; Liver; Mice; Non-alcoholic Fatty Liver Disease; Protein Serine-Threonine Kinases; Triglycerides | 2023 |
Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways.
Topics: AMP-Activated Protein Kinases; Animals; Gene Expression Regulation; Hep G2 Cells; Humans; Inflammation; Iridoids; Lipids; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Palmitic Acid; Phosphatidylinositol 3-Kinases; Phosphorylation; Polyethylene Glycols; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |
Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease.
Topics: Animals; Chlorogenic Acid; Colon; Disease Models, Animal; Down-Regulation; Drugs, Chinese Herbal; Gastrointestinal Microbiome; Glutathione; Humans; Intestinal Mucosa; Iridoids; Lipid Metabolism; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Signal Transduction; T-Lymphocytes, Regulatory; Transcriptome | 2017 |
[Mechanism of geniposide in improving free fatty acid metabolism in rats with non-alcoholic fatty liver disease].
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Drugs, Chinese Herbal; Fatty Acids, Nonesterified; Humans; Iridoids; Liver; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Triglycerides | 2016 |
Eucommia ulmoides cortex, geniposide and aucubin regulate lipotoxicity through the inhibition of lysosomal BAX.
Topics: Animals; bcl-2-Associated X Protein; Cathepsin B; Cell Death; Diet, High-Fat; Enzyme Inhibitors; Eucommiaceae; Female; Humans; Iridoid Glucosides; Iridoids; Liver; Lysosomes; Non-alcoholic Fatty Liver Disease; Palmitates; Rats; Rats, Sprague-Dawley | 2014 |
Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Cytochrome P-450 CYP2E1; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fatty Liver; Insulin; Iridoids; Lipid Metabolism; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; PPAR alpha; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2011 |